Physical Therapy Exercises in Hyperkyphosis

September 30, 2021 updated by: Karina Zapata, PT, DPT, PhD, Texas Scottish Rite Hospital for Children

Effectiveness of Physical Therapy Exercises in Hyperkyphosis

This proposal is a single center preliminary prospective cohort trial that evaluates patients with hyperkyphosis. Participants will receive physical therapy exercises and be followed for the above outcome measures over time. The treatment arm will receive training in one-time training in kyphosis-specific exercises.

It is hypothesized that participants receive physical therapy exercises will demonstrate improved outcome measures over time. Also, it is hypothesized that participants who receive kyphosis-specific exercises will demonstrate significantly improved perceived quality-of-life and significantly reduced pain, compared to participants who receive generalized back exercises after 6 months.

Also, it is hypothesized that a kyphosis-specific SAQ will demonstrate satisfactory test-retest reliability and concurrent validity.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

A total of 50 patients will be recruited for this study. 28 patients will be recruited for both groups, or 14 participants per group. Patients will be randomized by an independent research assistant who will draw the group number from a hat. We assume less than 15% attrition, which results in 12 participants per group.

Patients in both groups will ideally be followed after 6 months, unless the patient's treating orthopaedic surgeon schedules them for a visit up until 12 months later.

Group 1(Kyphosis-specific exercise Group): Patients will receive a one-time treatment consisting of kyphosis-specific exercises that promote depressing the thoracic convexity.

Group 2 (Generalized exercise group): Patients will receive a one-time treatment consisting of core strengthening, hamstring stretching, and generalized back extension exercises.

Patients in each group will be asked to perform these exercises at home about 10 minutes a day, 3 times a week.

Each patient will be given access to a software application though PT PAL on their smart phone (or computer). Patients will be asked to use the app whenever they perform their exercises throughout the 6 month period. Patients must turn off the app after 15 minutes for the app to count the exercise session as complete. Each physical therapist participating in the study will have administrator access to monitor exercise adherence for their respective patients at any time as a tool to maximize exercise adherence.

Each patient will also be asked about their pain intensity on a monthly basis through a secure database (REDCap).

5. Study Procedures: Group 1 or 2

Month 0 (40 minutes):

  • X-ray of back [standard of care]
  • Picture of back [research]
  • Physical therapy program [research]
  • Two surveys on how kyphosis affects the patient [research]
  • Physical examination [research]

Week 2 (10 minutes):

  • Two surveys at home on how kyphosis affects the patient [research]

Months 1-5 (2 minutes)

• Monthly survey at home regarding your back pain [research]

Month 6-12 (40 minutes):

  • X-ray of back [standard of care]
  • Picture of back [research]
  • Two surveys on how kyphosis affects the patient [research]
  • Physical examination [research]

These x-rays will not need to be ordered as a study procedure.

5a. Sub-Study: Aim 2 Kyphosis-Specific SAQ (K-SAQ) The secondary aim of this study is to assess the psychometric properties of a kyphosis-specific SAQ and evaluate the test-retest reliability and concurrent validity of this kyphosis-specific SAQ.

The original study design included enrolling a total of 28 patients, all of whom would receive and complete the SRS-22 and the kyphosis-specific SAQ at baseline, two weeks, and 6-12 month follow-up.

At the conclusion of initial enrollment, 21 patients had been enrolled and six (6) were lost to follow-up. Of the 21 total patients, 15 completed Aim 1 of this study, not all of which completed Aim 2.

During analysis, we found statistical significance for the test-retest reliability and concurrent validity of the K-SAQ, but due to weak enrollment and completion of the questionnaires at baseline and two weeks, we are enrolling more patients for Aim 2 of the original study design and will end enrollment for Aim 2 at the conclusion of 25 completed responses of the K-SAQ and SRS-22 for both baseline and 2-week follow-up.

We will increase enrollment from 28 patients to 50 patients.

Patients in this sub-group must be diagnosed with hyperkyphosis, have a Cobb angle of at least 50°, and be 8-21 years old. Exclusion criteria includes: scoliosis greater than 25°, current brace wear, and previous spine surgery. Specific treatment is not a part of this sub-group.

Patients enrolled in the Kyphosis-specific SAQ Sub-group of the PPKS Registry (STU 032011-130) will be included within this sub-group for data analysis.

6. Criteria for Inclusion of Subjects: Patients with a diagnosis of hyperkyphosis meeting the following inclusion criteria will be eligible to participate: ages 10 to 18 years, Cobb angles at least 50°, and pain >2 on the VAS during the past week.

7. Criteria for Exclusion of Subjects:

Patients will be excluded according to the following exclusion criteria:

scoliosis greater than 25°, conditions preventing understanding and compliance with an exercise schedule, current brace wear, previous spine surgery, inability to commit to at least 15 minutes of exercises for 3 days a week, and pain <2 on the VAS during the past week.

8. Sources of Research Material: Baseline participant characteristics will include age, sex, ethnicity, Risser sign, height, weight, BMI, curve magnitude of a lateral radiograph, and location of the kyphosis apex. The lateral radiograph information will be obtained from Synapse, a radiology information system at TSRH.

Exercise adherence will be recorded including the length of exercise sessions and total duration of PT until the patient is discharged to a HEP. HEP adherence will be calculated as the percentage of prescribed exercises completed from baseline to 6 months.

9. Recruitment Methods and Consenting Process: Patients will be screened by the investigators, participating physical therapists, or research coordinator to determine whether inclusion criteria is met. If the patient is eligible for this trial, the patient will be offered enrollment to the patient and caregiver. Appropriate patient assent and caregiver consent to participate in the trial will be obtained per IRB protocol. The patient will then choose to be in either the treatment or observation group.

10. Potential Risks: Identifiable risk associated with participation in this study would be a potential loss of confidentiality and tired or sore muscles from the exercises.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Dallas, Texas, United States, 75219
        • Texas Scottish Rite Hospital for Children

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 16 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • diagnosis of hyperkyphosis
  • ages 10 to 18 years
  • Cobb angles at least 50°
  • pain >2 on the VAS during the past week.

Exclusion Criteria:

  • scoliosis greater than 25°
  • conditions preventing understanding and compliance with an exercise schedule
  • current brace wear
  • previous spine surgery
  • inability to commit to at least 15 minutes of exercises for 3 days a week
  • pain <2 on the VAS during the past week.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: Exercise
Schroth-based physical therapy exercises for patients who agree to participate in exercises. Will be compared to observation-only treatment
physical therapy exercises

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
survey
Time Frame: 6 month follow-up
19 items that identify factors related to exercise adherence, app usability and acceptability
6 month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain intensity
Time Frame: baseline
Numeric Pain Rating Scale
baseline
pain intensity
Time Frame: 6 month follow-up
Numeric Pain Rating Scale
6 month follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Karina A Zapata, PhD, Texas Scottish Rite Hospital for Children

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 5, 2014

Primary Completion (Actual)

March 1, 2017

Study Completion (Actual)

May 5, 2020

Study Registration Dates

First Submitted

July 3, 2017

First Submitted That Met QC Criteria

July 6, 2017

First Posted (Actual)

July 11, 2017

Study Record Updates

Last Update Posted (Actual)

October 8, 2021

Last Update Submitted That Met QC Criteria

September 30, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • 1143

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperkyphosis

Clinical Trials on exercise

3
Subscribe